Lactococcus lactis NZ3900/pNZ8149-IL-4-IL-2 as an adjuvant to reduce vaccine dose in chicken coccidia live mixed vaccine

Longlong Zheng, Li Zhang, Fan Tan, Honghui Zhang, Liming Wang, Mingxue Zheng

PDF
Animal Research and One Health ›› 2024, Vol. 2 ›› Issue (1) : 50-58. DOI: 10.1002/aro2.12
ARTICLE

Lactococcus lactis NZ3900/pNZ8149-IL-4-IL-2 as an adjuvant to reduce vaccine dose in chicken coccidia live mixed vaccine

Author information +
History +

Abstract

Although live mixed coccidiosis vaccines are widely used for Eimeria control, the side effects (e.g., damaging the intestinal mucosa and decreasing their weight gain) are not negligible. This study aimed to filter out the lowest dose of coccidiosis mixed vaccine with Lactococcus lactis (L. lactis) NZ3900/pNZ8149-IL-4-IL-2 (RLIL4/2) coimmunization against Eimeria reduces the side effects for Eimeria vaccination. Chickens oral 1.0 ×, 0.9 ×, 0.8 ×, 0.6 ×, 0.4 × dose of live vaccine, and RLIL4/2 with 1.0 × 109 CFU/chicken, respectively. The blank control group, challenge-only group and 1.0 × dose vaccine-only group are used as references. The survival rate, weight gain, bloody stool, intestinal lesions scores, oocyst output oocysts per gramme (OPG), and anticoccidial index (ACI) were detected by challenging with virulent coccidiosis. All the results indicated that the weight gain during the immune period or bloody stool/intestinal lesions scores/OPG during the challenge period were oppositely correlated with vaccine doses. The survival rate, weight gain, and ACI were positively correlated with vaccine doses during the challenge period. The ACI of 0.6 × the dose group was 167.69, which was considered a moderate efficiency. The weight gain, ACI of 1.0 ×, 0.9 × and 0.8 × dose groups were higher or intestinal lesions were lower than 1.0 × dose vaccine-only group (p < 0.05), respectively. In conclusion, the coimmunization of RLIL4/2 with Eimeria mixed vaccine could reduce 40% of the dose and the side effects (e.g., weight gain and intestinal lesions) from live mixed coccidiosis vaccine.

Keywords

adjuvant / chicken coccidia / Lactococcus lactis NZ3900/pNZ8149-IL-4-IL-2 / live mixed vaccine / side effect / vaccination dose

Cite this article

Download citation ▾
Longlong Zheng, Li Zhang, Fan Tan, Honghui Zhang, Liming Wang, Mingxue Zheng. Lactococcus lactis NZ3900/pNZ8149-IL-4-IL-2 as an adjuvant to reduce vaccine dose in chicken coccidia live mixed vaccine. Animal Research and One Health, 2024, 2(1): 50‒58 https://doi.org/10.1002/aro2.12

RIGHTS & PERMISSIONS

2023 2023 The Authors. Animal Research and One Health published by John Wiley & Sons Australia, Ltd on behalf of Institute of Animal Science, Chinese Academy of Agricultural Sciences.
PDF

Accesses

Citations

Detail

Sections
Recommended

/